Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular risk indices in type 2 diabetes versus polycystic ovarian syndrome and modification by metformin or pioglitazone
2005-000461-18Phase 4Completed
- Sponsor
- University of Hull
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS) comparing Metformin with Pioglitazone (2 arms). Primary endpoints: Change in insulin resistance by insulin clamp and Change in endothelial function by flow-mediated vasodilation. Started Feb 2005; status: completed.
02
Drugs
metforminpioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2005-000461-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000461-18.